DE3584852D1 - Antikonvulsive verbindungen. - Google Patents

Antikonvulsive verbindungen.

Info

Publication number
DE3584852D1
DE3584852D1 DE8585303451T DE3584852T DE3584852D1 DE 3584852 D1 DE3584852 D1 DE 3584852D1 DE 8585303451 T DE8585303451 T DE 8585303451T DE 3584852 T DE3584852 T DE 3584852T DE 3584852 D1 DE3584852 D1 DE 3584852D1
Authority
DE
Germany
Prior art keywords
convulsive
connections
convulsive connections
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8585303451T
Other languages
English (en)
Inventor
Masayuki Teranishi
Chikara Murakata
Ikuo Matsukuma
Katsuichi Shuto
Shunji Ichikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of DE3584852D1 publication Critical patent/DE3584852D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585303451T 1984-05-16 1985-05-16 Antikonvulsive verbindungen. Expired - Lifetime DE3584852D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59098193A JPS60243017A (ja) 1984-05-16 1984-05-16 抗けいれん組成物

Publications (1)

Publication Number Publication Date
DE3584852D1 true DE3584852D1 (de) 1992-01-23

Family

ID=14213165

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585303451T Expired - Lifetime DE3584852D1 (de) 1984-05-16 1985-05-16 Antikonvulsive verbindungen.

Country Status (4)

Country Link
US (1) US4588729A (de)
EP (1) EP0162669B1 (de)
JP (1) JPS60243017A (de)
DE (1) DE3584852D1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19500118A1 (de) * 1994-05-18 1995-11-23 Bayer Ag Substituierte Diazacyclohexandi(thi)one
DE4440914A1 (de) * 1994-11-17 1996-05-23 Bayer Ag Substituierte Diazacyclohexandi(thi)one
EP0885197A1 (de) * 1996-03-07 1998-12-23 American Home Products Corporation 2-thioxotetrahydropyrimidin-4-on-derivate
US7501429B2 (en) * 2001-04-11 2009-03-10 Queen's University At Kingston Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents
EP1397136A1 (de) * 2001-05-25 2004-03-17 Queen's University At Kingston Heterocyclische beta-aminosaure und deren verwendung als antiepileptogene verbindungen
WO2004009559A2 (en) * 2002-07-18 2004-01-29 Queen's University At Kingston Dihydrouracil compounds as anti-ictogenic or anti-epileptogenic agents
US20050096319A1 (en) * 2003-02-21 2005-05-05 Balzarini Jan M.R. Identification of compounds that inhibit replication of human immunodeficiency virus
EP1603546A1 (de) * 2003-02-21 2005-12-14 Tripep AB Glycinamid-derivat zur hemmung der hiv-replikation
ATE519746T1 (de) 2007-09-17 2011-08-15 Abbott Lab Antiinfektiöse pyrimidine und anwendungen davon
SG183733A1 (en) 2007-09-17 2012-09-27 Abbott Lab Uracil or thymine derivative for treating hepatitis c
MX2010002904A (es) 2007-09-17 2010-06-02 Abbott Lab N-fenil-dioxo-hidropirimidinas utiles como inhibidores de virus de hepatitis c (hcv).
US9216952B2 (en) 2010-03-23 2015-12-22 Abbvie Inc. Process for preparing antiviral compound
US8975443B2 (en) 2010-07-16 2015-03-10 Abbvie Inc. Phosphine ligands for catalytic reactions
KR101893751B1 (ko) 2010-07-16 2018-09-03 애브비 아일랜드 언리미티드 컴퍼니 항바이러스성 화합물의 제조 방법
BR112013001138A2 (pt) 2010-07-16 2016-07-05 Abbvie Inc ligantes de fosfina para reações catalíticas
US9255074B2 (en) 2010-07-16 2016-02-09 Abbvie Inc. Process for preparing antiviral compounds
EP2941423B1 (de) 2013-01-07 2021-06-09 University of Southern California Deoxyuridintriphosphatase-inhibitoren
CA2991468A1 (en) 2015-07-08 2017-01-12 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2017006270A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors
WO2017006271A1 (en) 2015-07-08 2017-01-12 University Of Southern California Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage
WO2017006283A1 (en) 2015-07-08 2017-01-12 Cv6 Therapeutics (Ni) Limited Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage
US10829457B2 (en) 2016-11-23 2020-11-10 Cv6 Therapeutics (Ni) Limited Nitrogen ring linked deoxyuridine triphosphatase inhibitors
WO2018098209A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited Amino sulfonyl compounds
US11174271B2 (en) 2016-11-23 2021-11-16 Cv6 Therapeutics (Ni) Limited 6-membered uracil isosteres
WO2018098206A1 (en) 2016-11-23 2018-05-31 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
US11014924B2 (en) 2016-11-23 2021-05-25 Cv6 Therapeutics (Ni) Limited Hydantoin containing deoxyuridine triphosphatase inhibitors
WO2018128720A1 (en) * 2017-01-05 2018-07-12 Cv6 Therapeutics (Ni) Limited Uracil containing compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3360523A (en) * 1964-06-17 1967-12-26 Du Pont 3, 5, 6-substituted hydrouracils
JPS55108858A (en) * 1979-02-14 1980-08-21 Kyowa Hakko Kogyo Co Ltd Novel dihydrouracil derivative and herbicide
JPS5753481A (en) * 1980-09-17 1982-03-30 Yoshitomi Pharmaceut Ind Ltd 4-hydrouracil-piperidines

Also Published As

Publication number Publication date
US4588729A (en) 1986-05-13
JPS60243017A (ja) 1985-12-03
EP0162669A3 (en) 1986-11-20
EP0162669A2 (de) 1985-11-27
EP0162669B1 (de) 1991-12-11

Similar Documents

Publication Publication Date Title
DE3584852D1 (de) Antikonvulsive verbindungen.
DE3672133D1 (de) Wirksame verbindungen.
FI851907A0 (fi) Nytt foerfarande foer syntetisering av pyridoimidazorifamyciner.
DE3583900D1 (de) Adrenergische verbindungen.
FI83882B (fi) Foerfarande foer framstaellning av blodlevring haemmande proteiner.
DE3577009D1 (de) Photochrome verbindungen.
FI850296A0 (fi) Nytt foerfarande foer limning av papper.
FI850174L (fi) Foerfarande foer framstaellning av (5-het-)metylenpenemer.
DE3586547T2 (de) Antibakterielle verbindungen.
FI840174A (fi) Foerfarande foer optisk maetning av laongstraeckta stycken.
DE3586406D1 (de) Tabelliersystem.
FI80896B (fi) Foerfarande foer framstaellning av fenolskum.
DE3578424D1 (de) Quino-benzothiazin-antibakterielle verbindungen.
FI860739A0 (fi) Undervattensopererande system.
FI842516A0 (fi) System foer automatisk tryckreglering av luftkuddeelement.
FI840758A (fi) Anlaeggning foer utnyttjande av vaermeenergi alstrad av en bastuugn.
FI850923L (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara /(2-hydroxi-fenyl)metylenamino/ fenylalkankarboxylsyraderivat.
IT8523063A0 (it) Mezzi fungicidi-selettivi.
FI841198A0 (fi) Nytt foerfarande foer framstaellning av - glutamyltarin.
FI883773A0 (fi) Foerfarande foer framstaellning av (1-fenyletyl) hydrokinon.
FI842673A0 (fi) Anordning speciellt foer behandling av avfallsvatten.
ATE47325T1 (de) Spielbausteinsystem.
FI80875B (fi) Framstaellning av isobutyrylfluorid.
FI841455A0 (fi) System foer utvinning av vaermeenergi.
FI842026A0 (fi) System foer centrering av solstraolning.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee